Nuo Therapeutics AURX
OTC AURX
$1.30 +0.01 (+0.78%)
As of: Oct 23, 2026 · 9:44 AM EDT

Nuo Therapeutics (AURX) Non Operating Investment Income (2014)

Updated

Nuo Therapeutics (AURX) reported Non Operating Investment Income of -$6,754 for FY2015, compared with -$131,456 in FY2014.

Analysis

Nuo Therapeutics (AURX) Non Operating Investment Income (2014) Analysis & Trends

  • According to Business Quant data, Non Operating Investment Income came in at -$131,456 in FY2014 and $594,173 in FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.17 Bn 228.32 Bn 4.88 Bn
2 Abbott Laboratories 179.42 Bn 150.51 Bn 7.27 Bn
3 Danaher 161.98 Bn 145.80 Bn 3.61 Bn
4 Intuitive Surgical 156.76 Bn 137.18 Bn 2.08 Bn
5 Medtronic 122.13 Bn 88.00 Bn 6.34 Bn
6 Stryker 117.84 Bn 103.96 Bn 4.50 Bn
7 Boston Scientific 66.19 Bn 61.20 Bn 3.85 Bn
8 Becton Dickinson 54.16 Bn 51.31 Bn 2.32 Bn
9 Edwards Lifesciences 51.35 Bn 35.47 Bn 1.35 Bn
10 Nuo Therapeutics 62.96 Mn 61.13 Mn 1.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2014 -132,000.00
API Access

Nuo Therapeutics Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=AURX&period=max&api_key=YOUR_API_KEY